ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Spatial occurrence of glaucomatous visual field damage in the combined 24-2 and 10-2 test locations.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of the Reaction Time-Based False-Positive Rate as a Reliability Index for Standard Automated Perimetry.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study identified areas where glaucomatous visual field (VF) defects most and least frequently occur in the combined 24–2 and 10–2 test locations.
methodsFive hundred three eyes of 503 glaucoma patients were included. All patients underwent both 24–2 (or 30–2) and 10–2 tests using the Humphrey Visual Field Analyzer. An abnormal test location was defined as a total deviation probability of < 5%. The combined dataset of 24–2 and 10–2 test locations was resampled using the bootstrap method. Test locations were classified into six grades based on the percentile ranks of abnormality frequency. Hierarchical cluster analysis was additionally performed to explore spatial patterns of abnormal test locations.
resultsThe mean age of the participants was 61.4 ± 12.7 years. The median mean deviation (MD) of the 24–2 (or 30–2) and 10–2 tests was -5.2 dB (interquartile range [IQR]: -11.7 to -2.1) and -4.0 dB (IQR: -11.2 to -1.5), respectively. Abnormal test locations were most frequently observed in the superior nasal area of the combined test grids. Conversely, the lowest frequency of glaucomatous damage was observed in the central inferior region adjacent to the physiological blind spot. Hierarchical cluster analysis identified 27 clusters, broadly divided into superior and inferior regions by the horizontal meridian.
conclusionSuperior nasal locations are important for detecting early glaucomatous VF changes, whereas central inferior locations adjacent to the physiological blind spot are useful for assessing residual visual function in advanced disease. Our results inform optimized selection of VF test locations by disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.